Somewhat Positive Press Coverage Somewhat Unlikely to Impact DENTSPLY SIRONA (XRAY) Share Price
Press coverage about DENTSPLY SIRONA (NASDAQ:XRAY) has been trending somewhat positive on Friday, according to Accern. The research group identifies positive and negative news coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. DENTSPLY SIRONA earned a media sentiment score of 0.07 on Accern’s scale. Accern also gave headlines about the medical instruments supplier an impact score of 46.1853245578408 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.
Here are some of the headlines that may have effected Accern Sentiment Analysis’s rankings:
- Eric Brandt Sells 6,409 Shares of DENTSPLY SIRONA Inc (XRAY) Stock (americanbankingnews.com)
- DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – Track P/E Before Buying A Stock – Nasdaq Journal (press release) (nasdaqjournal.com)
- Tale of the Ticker: Dentsply Sirona Inc (XRAY), Future Fintech Group Inc (FTFT) Moving on Volume – Clawson News (clawsonnews.com)
- Facts About In Play Stocks: DENTSPLY SIRONA Inc (NASDAQ: XRAY) – Alpha Beta Stock (alphabetastock.com)
- Are you searching Analysts Rated Stock: DENTSPLY SIRONA Inc. (XRAY) – Wall Street Morning (wallstreetmorning.com)
Shares of DENTSPLY SIRONA (XRAY) traded up $1.54 during mid-day trading on Friday, reaching $65.79. The company had a trading volume of 1,667,132 shares, compared to its average volume of 2,444,056. DENTSPLY SIRONA has a 52-week low of $52.53 and a 52-week high of $68.98. The firm has a market capitalization of $15,070.00, a price-to-earnings ratio of -18.91, a PEG ratio of 2.49 and a beta of 1.31. The company has a debt-to-equity ratio of 0.21, a current ratio of 2.32 and a quick ratio of 1.59.
DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Friday, November 3rd. The medical instruments supplier reported $0.70 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.66 by $0.04. DENTSPLY SIRONA had a positive return on equity of 7.56% and a negative net margin of 20.33%. The firm had revenue of $1.01 billion for the quarter, compared to analyst estimates of $978.99 million. During the same quarter in the prior year, the company posted $0.66 earnings per share. DENTSPLY SIRONA’s quarterly revenue was up 5.8% on a year-over-year basis. equities research analysts anticipate that DENTSPLY SIRONA will post 2.65 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 12th. Investors of record on Friday, December 29th will be issued a dividend of $0.0875 per share. This represents a $0.35 dividend on an annualized basis and a yield of 0.53%. The ex-dividend date is Thursday, December 28th. DENTSPLY SIRONA’s dividend payout ratio is presently -10.06%.
A number of equities research analysts have weighed in on XRAY shares. Deutsche Bank started coverage on DENTSPLY SIRONA in a research note on Friday, December 8th. They issued a “buy” rating and a $81.00 price objective for the company. Zacks Investment Research raised DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a report on Friday, October 20th. BidaskClub lowered DENTSPLY SIRONA from a “strong-buy” rating to a “buy” rating in a report on Saturday, December 2nd. Cleveland Research lowered DENTSPLY SIRONA from a “buy” rating to a “neutral” rating in a report on Thursday, October 5th. Finally, Credit Suisse Group lowered DENTSPLY SIRONA to a “hold” rating and set a $73.00 target price on the stock. in a report on Friday, January 5th. Two research analysts have rated the stock with a sell rating, four have issued a hold rating and nine have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $69.15.
In other DENTSPLY SIRONA news, CFO Nicholas W. Alexos acquired 50,000 shares of the company’s stock in a transaction that occurred on Monday, November 13th. The shares were purchased at an average price of $65.85 per share, with a total value of $3,292,500.00. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Mark Thierer acquired 77,000 shares of the company’s stock in a transaction that occurred on Monday, November 13th. The shares were acquired at an average cost of $66.04 per share, for a total transaction of $5,085,080.00. The disclosure for this purchase can be found here. Corporate insiders own 1.99% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “Somewhat Positive Press Coverage Somewhat Unlikely to Impact DENTSPLY SIRONA (XRAY) Share Price” was posted by Daily Political and is the sole property of of Daily Political. If you are accessing this story on another publication, it was illegally copied and reposted in violation of U.S. and international copyright and trademark legislation. The legal version of this story can be read at https://www.dailypolitical.com/2018/01/12/somewhat-positive-press-coverage-somewhat-unlikely-to-impact-dentsply-sirona-xray-share-price.html.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.